Literature DB >> 16330707

Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Anne L Taylor1, Jackson T Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330707     DOI： 10.1161/CIRCULATIONAHA.105.540443

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  21 in total

Review 1.  Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review.

Authors:  Ina U Park; Anne L Taylor
Journal:  Ann Fam Med       Date:  2007 Sep-Oct       Impact factor: 5.166

2.  Physicians' anxiety due to uncertainty and use of race in medical decision making.

Authors:  Brooke A Cunningham; Vence L Bonham; Sherrill L Sellers; Hsin-Chieh Yeh; Lisa A Cooper
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

3.  Advancing Health Services Research to Eliminate Health Care Disparities.

Authors:  Joan Wasserman; Richard C Palmer; Marcia M Gomez; Rick Berzon; Said A Ibrahim; John Z Ayanian
Journal:  Am J Public Health       Date:  2019-01       Impact factor: 9.308

4.  Race Effects in CVD Prediction Models.

Authors:  Utibe R Essien; Larry R Jackson
Journal:  J Gen Intern Med       Date:  2019-04       Impact factor: 5.128

Review 5.  Hypertension in black Americans as a special population: why so special?

Authors:  David Stewart; Wallace Johnson; Elijah Saunders
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

6.  Comparison in the incidence of anorectal malformations between a first- and third-world referral center.

Authors:  Andre P Theron; Giulia Brisighelli; Anne E Theron; Ernesto Leva; Alp Numanoglu
Journal:  Pediatr Surg Int       Date:  2015-07-01       Impact factor: 1.827

7.  The complex relationship of race to outcomes in heart failure with preserved ejection fraction.

Authors:  Jerry H Gurwitz; David J Magid; David H Smith; Grace Hsu; Sue Hee Sung; Larry A Allen; David D McManus; Robert J Goldberg; Alan S Go
Journal:  Am J Med       Date:  2014-12-30       Impact factor: 4.965

8.  Disparity in race-specific comorbidities associated with central venous catheter-related bloodstream infection (AHRQ-PSI7).

Authors:  James Studnicki; Bola F Ekezue; Maka Tsulukidze; Peggy Honoré; Ramal Moonesinghe; John Fisher
Journal:  Am J Med Qual       Date:  2013-03-24       Impact factor: 1.852

9.  Family physicians' beliefs about genetic contributions to racial/ethnic and gender differences in health and clinical decision-making.

Authors:  Esther Warshauer-Baker; Vence L Bonham; Jean Jenkins; Nancy Stevens; Zintesia Page; Adebola Odunlami; Colleen M McBride
Journal:  Community Genet       Date:  2008-08-05

10.  Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitor-Based Treatment on Cardiovascular Outcomes in Hypertensive Blacks Versus Whites.

Authors:  Gbenga Ogedegbe; Nirav R Shah; Christopher Phillips; Keith Goldfeld; Jason Roy; Yu Guo; Joyce Gyamfi; Christopher Torgersen; Louis Capponi; Sripal Bangalore
Journal:  J Am Coll Cardiol       Date:  2015-09-15       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.